Evidence map›Paper›PMID 26754738›Full record

ArticleImmunogenetics2016

Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

John Sidney, Jennifer Schloss, Carrie Moore, Mikaela Lindvall, Amanda Wriston, Donald F Hunt, Jeffrey Shabanowitz, Teresa P DiLorenzo, Alessandro Sette

Abstract read
In one paragraph

Article in Immunogenetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

John SidneyLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Jennifer SchlossDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA.
Carrie MooreLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Mikaela LindvallLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.
Amanda WristonDepartment of Chemistry, University of Virginia, Charlottesville, VA, 222904, USA.
Donald F HuntDepartments of Chemistry and Pathology, University of Virginia, Charlottesville, VA, 222904, USA.
Jeffrey ShabanowitzDepartment of Chemistry, University of Virginia, Charlottesville, VA, 222904, USA.
Teresa P DiLorenzoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA.
Alessandro SetteLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA. alex@liai.org.
La Jolla Institute for Immunology · USUniversity of Virginia · USAlbert Einstein College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY E. PESSIN · 2015 to 2026
$27.7M
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRYR01AI033993 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1994 to 2017
$4.9M
Antigens Recognized by CD8+ T Cells in Type 1 DiabetesR01DK064315 · NIDDK · YESHIVA UNIVERSITY · PI DILORENZO, TERESA P · 2003 to 2015
$3.8M
T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic CellsR01DK094327 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DILORENZO, TERESA P · 2011 to 2015
$1.8M
Use of beta cell epitopes in preventing type 1 diabetes in humanized miceF30DK103368 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SCHLOSS, JENNIFER · 2014 to 2018
$198k
CD8 T Cell Epitope Mapping Using Mice Expressing HLA-A2 and a Human AutoantigenR03AI119225 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DILORENZO, TERESA P · 2015 to 2016
$167k
NIAID NIH HHS HHSN272201400045CNIAID NIH HHS R01 AI033993NIAID NIH HHS R03 AI119225NIDDK NIH HHS F30 DK103368NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P60 DK020541NIDDK NIH HHS R01 DK064315NIDDK NIH HHS R01 DK094327NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

B*38:01 and B*39:06 are present with phenotypic frequencies <2% in the general population, but are of interest as B*39:06 is the B allele most associated with type 1 diabetes susceptibility and 38:01 is most protective. A previous study derived putative main anchor motifs for both alleles based on peptide elution data. The present study has utilized panels of single amino acid substitution peptide libraries to derive detailed quantitative motifs accounting for both primary and secondary influences on peptide binding. From these analyses, both alleles were confirmed to utilize the canonical position 2/C-terminus main anchor spacing. B*38:01 preferentially bound peptides with the positively charged or polar residues H, R, and Q in position 2 and the large hydrophobic residues I, F, L, W, and M at the C-terminus. B*39:06 had a similar preference for R in position 2, but also well-tolerated M, Q, and K. A more dramatic contrast between the two alleles was noted at the C-terminus, where the specificity of B*39:06 was clearly for small residues, with A as most preferred, followed by G, V, S, T, and I. Detailed position-by-position and residue-by-residue coefficient values were generated from the panels to provide detailed quantitative B*38:01 and B*39:06 motifs. It is hoped that these detailed motifs will facilitate the identification of T cell epitopes recognized in the context of two class I alleles associated with dramatically different dispositions towards type 1 diabetes, offering potential avenues for the investigation of the role of CD8 T cells in this disease.

Indexed as

Amino Acid SequenceHLA-B38 AntigenHLA-B39 AntigenHumansPeptidesProtein BindingHLA-B38 AntigenHLA-B39 AntigenPeptidesAntigen presentationEpitopesMajor histocompatibility complexType 1 diabetes

Identifiers

PMID26754738
PMCPMC4760861
OpenAlexW2232785582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.